EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The anticancer effect of metformin targets VDAC1 via ER-mitochondria interactions-mediated autophagy in HCC

Minjeong Ko, Jiho Kim, Raudah Lazim, Ju Yeon Lee iD, Jin Young Kim iD, Vijayakumar Gosu, Yoonji Lee iD, Sun Choi, Ho Jeong Kwon iD

Experimental & Molecular Medicine · 03.12.2024 · 56 (12) · 2714-2725

DOI: 10.1038/s12276-024-01357-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental & Molecular Medicine, online erschienen am 03.12.2024. Verfasst von Minjeong Ko und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Genomics Leader Research Laboratory, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Repub…. Hauptthemen laut MEDLINE: Voltage-Dependent Anion Channel 1, Metformin, Autophagy, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the national research foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin (MetF) is used worldwide as a first-line therapy for type 2 diabetes. Recently, interest in the pleiotropic effects of MetF, such as its anticancer and antiaging properties, has increased. However, the molecular target of MetF and the detailed mechanism underlying its ability to inhibit cell growth through autophagy induction remain incompletely understood. In this study, using an innovative label-free drug affinity responsive target stability (DARTS)-LC-MS/MS method, we discovered that mitochondrial voltage-dependent anion channel 1 (VDAC1) is a novel binding protein involved in the induction of autophagy-related cell death by high-dose MetF in hepatocellular carcinoma (HCC). Computational alanine scanning mutagenesis revealed that MetF and VDAC1 (D9, E203) interact electrostatically. MetF disrupts the IP 3 R-GRP75-VDAC1 complex, which plays a key role in stabilizing mitochondria-associated ER membranes (MAMs), by binding to VDAC1. This disruption leads to increased cytosolic calcium levels, thereby contributing to autophagy induction. MetF also decreased the AMP/ATP ratio and activated the AMPK pathway. Cells with genetic knockdown of VDAC1 mimicked the activity of MetF. In conclusion, this study provides new insights into the involvement of MetF in ionic interactions with VDAC1, contributing to its anticancer effects in HCC. These findings help elucidate the diverse biological and pharmacological effects of MetF, particularly its influence on autophagy, as well as the potential of MetF as a therapeutic agent for diseases characterized by VDAC1 overexpression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Voltage-Dependent Anion Channel 1MetforminAutophagyCarcinoma, HepatocellularLiver NeoplasmsMitochondriaEndoplasmic ReticulumHumansCell Line, TumorAntineoplastic AgentsProtein BindingAnimals

Substanzen

Voltage-Dependent Anion Channel 1MetforminVDAC1 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Chemical Genomics Leader Research Laboratory, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.
  • Global AI Drug Discovery Center, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.
  • Research Center of Bioconvergence Analysis, Korea Basic Science Institute, Ochang, Republic of Korea.
  • Critical Diseases Diagnostics Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
  • Global AI Drug Discovery Center, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea. sunchoi@ewha.ac.kr.
  • Chemical Genomics Leader Research Laboratory, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea. kwonhj@yonsei.ac.kr.

ORCID-Profile: Ju Yeon Lee, Jin Young Kim, Yoonji Lee, Ho Jeong Kwon

Förderung

  • the national research foundation of Korea

Zitieren

APA

Ko, M., Kim, J., Lazim, R., Lee, J. Y., Kim, J. Y., Gosu, V., Lee, Y., Choi, S., & Kwon, H. J. (2024). The anticancer effect of metformin targets VDAC1 via ER-mitochondria interactions-mediated autophagy in HCC. Experimental & Molecular Medicine, 56(12), 2714-2725. https://doi.org/10.1038/s12276-024-01357-1

Vancouver

Ko M, Kim J, Lazim R, Lee JY, Kim JY, Gosu V, et al. The anticancer effect of metformin targets VDAC1 via ER-mitochondria interactions-mediated autophagy in HCC. Experimental & Molecular Medicine. 2024;56(12):2714-2725. doi:10.1038/s12276-024-01357-1

BibTeX
@article{Ko2024,
  author = {Ko, Minjeong and Kim, Jiho and Lazim, Raudah and Lee, Ju Yeon and Kim, Jin Young and Gosu, Vijayakumar and Lee, Yoonji and Choi, Sun and Kwon, Ho Jeong},
  title = {The anticancer effect of metformin targets VDAC1 via ER-mitochondria interactions-mediated autophagy in HCC},
  journal = {Experimental & Molecular Medicine},
  year = {2024},
  volume = {56},
  number = {12},
  pages = {2714--2725},
  doi = {10.1038/s12276-024-01357-1}
}
Kostenlos starten →